БАРИАТРИЯЛЫК ХИРУРГИЯДАГЫ ЖАҢЫ МЕТОДОР: СЕМИРҮҮЛҮКТҮ ЖАНА 2-ТҮРДӨГҮ КАНТ ДИАБЕТИН ДАРЫЛООНУН НАТЫЙЖАЛАРЫН ЖАКШЫРТУУ (АДАБИЯТТАРГА СЕРЕП)
DOI:
https://doi.org/10.54890/1694-8882-2024-5-74Аннотация
Заманбап дүйнөдө бариатриялык жана метаболикалык хирургия оорулуу семирүүнү жана 2-типтеги диабет, артериялык гипертензия жана дислипидемия сыяктуу аны менен байланышкан ооруларды дарылоонун эң натыйжалуу ыкмаларынын бири болуп саналат. Дүйнө жүзүндө ашыкча салмактуу жана семиз адамдардын саны өсүп жаткандыктан, бариатрия хирургиясына болгон муктаждык да өсүүдө. Кыска мөөнөттөгү бариатриялык хирургиянын жогорку эффективдүүлүгүнө карабастан, операциядан кийинки салмакты калыбына келтирүү маселеси олуттуу көйгөй бойдон калууда, бул узак мөөнөттүү дарылоонун натыйжаларын төмөндөтөт жана кошумча оорулардын кайталануу коркунучун жогорулатат. Арасында колдонуудагы ыкмаларын алдын алуу үчүн салмагын жогорулатуу: жогорулатуу мальабсорбции же күчөтүлгөн чектөө негизги операция менен бирге баштапкы ленталарды колдонуу. Перспективдүү чечим катары, күчөтүлгөн чектөөнүн жана антирефлюкс эффектинин артыкчылыктарын айкалыштырган фундапликация (FundoRing) менен бир-анастомотикалык ашказанды айланып өтүү ыкмасы сунушталат. Бул кайра салмактуулукту алдын алууга жана зат алмашуунун натыйжаларын жакшыртууга жардам берет, лента жана мальабсорбция менен байланышкан кыйынчылыктардын рискин азайтат. Бирок, бул ыкманын натыйжалуулугун жана коопсуздугун тастыктоо үчүн бейтаптарды узак мөөнөттүү байкоо менен кошумча рандомизацияланган изилдөөлөр талап кылынат. Ошентип, FundoRing ыкмасы салттуу ыкмаларга келечектүү альтернатива болуп саналат жана семирүү эпидемиясы жана анын кесепеттери менен күрөшүүдө олуттуу кадам болушу мүмкүн.
Ключові слова:
бариатриялык жана метаболикалык хирургия, 2-типтеги кант диабети, салмак кошуу, FundoRing, ашказан айлантуу, ашказан резекциясы, чектөөнү күчөтүү, билиопанкреатикалык айланма, фундопликацияПосилання
1. World Obesity Federation. World Obesity Atlas 2023. Available from: https://data.worldobesity.org/publications/?cat=19
2. World Obesity Federation. World Obesity Atlas 2024. Available from: https://data.worldobesity.org/publications/?cat=22
3. Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5(4):1218-1240. https://doi.org/10.3390/nu5041218
4. Bogers RP, Bemelmans WJ, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007;167 (16):1720-1728. https://doi.org/10.1001/ archinte.167.16.1720
5. Abdullah A, Peeters A, de Courten M, Stoelwinder J. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract. 2010;89(3):309-319. https://doi.org/10.1016/j.diabres.2010.04.012
6. IDF Diabetes Atlas 10th edition. Available from: https://diabetesatlas.org/atlas/tenth-edition/
7. Syn NL, Cummings DE, Wang LZ, Lin DJ, Zhao JJ, Loh M, et al. Association of metabolic–bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants. Lancet. 2021;397(10287):1830–1841. https://doi.org/10.1016/S0140-6736(21)00591-2
8. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Capristo E, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2021;397(10271):293-304. https://doi.org/10.1016/S0140-6736(20)32649-0
9. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386(9997):964-73. https://doi.org/10.1016/S0140-6736(15)00075-6
10. Voorwinde V, Steenhuis IHM, Janssen IMC, Monpellier VM, van Stralen MM. Definitions of long-term weight regain and their associations with clinical outcomes. Obes Surg. 2020;30(2):527–36. https://doi.org/10.1007/s11695-019-04210-x
11. Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879. https://doi.org/10.1001/ jama.2020.12567
12. Almalki OM, Lee WJ, Chen JC, Ser KH, Lee YC, Chen SC. Revisional Gastric Bypass for Failed Restrictive Procedures: Comparison of Single-Anastomosis (Mini-) and Roux-en-Y Gastric Bypass. Obes Surg. 2018;28(4):970-975. https://doi.org/10.1007/s11695-017-2991-0
13. Hedberg J, Sundström J, Sundbom M. Duodenal switch versus Roux-en-Y gastric bypass for morbid obesity: systematic review and meta-analysis of weight results, diabetes resolution and early complications in single-centre comparisons. Obes Rev. 2014;15(7):555-63. https://doi.org/10.1111/obr.12169
14. Salte OBK, Olbers T, Risstad H, Fagerland MW, Søvik TT, Blom-Høgestøl IK, et al. Ten-Year Outcomes Following Roux-en-Y Gastric Bypass vs Duodenal Switch for High Body Mass Index: A Randomized Clinical Trial. JAMA Netw Open. 2024;7(6):e2414340. https://doi.org/10.1001/jamanetworkopen.2024.14340
15. Pullman JS, Plank LD, Nisbet S, Murphy R, Booth MWC. Seven-Year Results of a Randomized Trial Comparing Banded Roux-en-Y Gastric Bypass to Sleeve Gastrectomy for Type 2 Diabetes and Weight Loss. Obes Surg. 2023;33(7):1989-1996. https://doi.org/10.1007/s11695-023-06635-x
16. Long SD, O’Brien K, MacDonald KG, Leggett-Frazier N, Swanson MS, Pories WJ, et al. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care. 1994;17(5):372–5. https://doi.org/10.2337/diacare.17.5.372
17. Buchwald H, Buchwald JN, McGlennon TW. Systematic review and meta-analysis of medium-term outcomes after banded Roux-en-Y gastric bypass. Obes Surg. 2014;24(9):1536-51. https://doi.org/10.1007/s11695-014-1311-1
18. O'Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, et al. Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding. Obes Surg. 2019;29(1):3-14. https://doi.org/10.1007/s11695-018-3525-0
19. Pavone G, Chierici A, Drai C, Alromayan M, Alamri A, Tartaglia N, et al. Banded versus non-banded Roux-en-Y gastric bypass: short, mid, and long-term surgical outcomes - a systematic review and meta-analysis. Surg Obes Relat Dis. 2024 Sep;20(9):880-889. https://doi.org/10.1016/j.soard.2024.05.010
20. Murphy R, Plank LD, Clarke MG, Evennett NJ, Tan J, Kim DDW, et al. Effect of Banded Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy on Diabetes Remission at 5 Years Among Patients With Obesity and Type 2 Diabetes: A Blinded Randomized Clinical Trial. Diabetes Care. 2022;45(7):1503-1511. https://doi.org/10.2337/dc21-2498
21. Lee WJ, Lin YH. Single-anastomosis gastric bypass (SAGB): appraisal of clinical evidence. Obes Surg. 2014;24:1749–1756. https://doi.org/10.1007/s11695-014-1369-9
22. Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: a meta-analysis. Clin Obes. 2018;8(3):159–169. https://doi.org/10.1111/cob.12246
23. IFSO. The 8th IFSO 2023 Registry Report. Available from: https://www.ifso.com/ifso-registry.php
24. Quint E, Perry ZH, Elkrinawi N, Kukeev I, Czeiger D, Vakhrushev A, et al. Banded One-Anastomosis Gastric Bypass (BOAGB) for Patients Living with Obesity and Extreme Obesity: A Single Institution's Experience. Obes Surg. 2024;34(5):1756-1763. https://doi.org/10.1007/s11695-024-07194-5
25. Cazzo E, Jimenez LS, Valerini FG, de Freitas Diniz TB, Ramos AC, Chaim EA. Weight Loss and Vomiting 1 Year After Banded Versus Non-banded One Anastomosis Gastric Bypass: a Prospective Randomized Trial. Obes Surg. 2020;30(5):1719-1725. https://doi.org/10.1007/s11695-020-04393-8
26. Miller KA, Radauer M, Buchwald JN, McGlennon TW, Ardelt-Gattinger E. 5-Year Results of Banded One-Anastomosis Gastric Bypass: a Pilot Study in Super-Obese Patients. Obes Surg. 2020;30(11):4307-4314. https://doi.org/10.1007/s11695-020-04824-6
27. Campanelli M, Bianciardi E, Benavoli D, Bagaglini G, Lisi G, Gentileschi P. Laparoscopic Banded One Anastomosis Gastric Bypass: A Single-Center Series. J Obes. 2022;2022:4942052. https://doi.org/10.1155/2022/4942052
28. Sheikh L., Pearless LA, Booth MW. Laparoscopic Silastic Ring Mini-Gastric Bypass (SR-MGBP): Up to 11-Year Results from a Single Centre. Obesity Surgery. 2017;27(9):2229–2234. https://doi.org/10.1007/s11695-017-2659-9
29. Parmar CD, Mahawar KK. One Anastomosis (Mini) Gastric Bypass Is Now an Established Bariatric Procedure: a Systematic Review of 12,807 Patients. Obes Surg. 2018;28(9):2956-2967. https://doi.org/10.1007/s11695-018-3382-x
30. Ponce de Leon-Ballesteros G, Romero-Velez G, Martinez-Portilla RJ, Pereira X, Roy-Garcia I, Fobi MAL, et al. Comparison of Outcomes Between Banded and Non-banded Sleeve Gastrectomy: a Systematic Review and Meta-analysis. Obes Surg. 2022;32(7):1-12. https://doi.org/10.1007/s11695-022-06043-7
31. Ospanov O. The Surgical Technique of Primary Modified Fundoplication Using the Excluded Stomach with Simultaneous Gastric Bypass. Obes Surg. 2023;33(4):1311-1313. https://doi.org/10.1007/s11695-023-06505-6
32. Ospanov O, Zharov N, Yelembayev B, Duysenov G, Volchkova I, Sultanov K, et al. A Three-Arm Randomized Controlled Trial of Primary One-Anastomosis Gastric Bypass: With FundoRing or Nissen Fundoplications vs. without Fundoplication for the Treatment of Obesity and Gastroesophageal Reflux Disease. Medicina (Kaunas). 2024 Feb 27;60(3):405. https://doi.org/10.3390/medicina60030405
33. Ospanov O, Yeleuov G, Buchwald JN, Zharov N, Yelembayev B, Sultanov K. A Randomized Controlled Trial of Acid and Bile Reflux Eso phagitis Prevention by Modified Fundoplication of the Excluded Stomach in One-Anastomosis Gastric Bypass: 1-Year Results of the FundoRing Trial. Obes Surg. 2023;33(7):1974-1983. https://doi.org/10.1007/s11695-023-06618-y
34. Werapitiya SB, Ruwanpura SP, Coulson TR. Laparoscopic Fundoplication Using the Excluded Stomach as a Novel Management Option for Refractory Bile Reflux Following One Anastomosis Gastric Bypass (OAGB). Obes Surg. 2022;32(2):561-566. https://doi.org/10.1007/s11695-021-05804-0
35. Soprani A, Boullenois H, Zulian V, Nedelcu A, Carandina S. One-Anastomosis Gastric Bypass and Hiatal Hernia: Nissen Fundoplication with the Excluded Stomach to Decrease the Risk of Postoperative Gastroesophageal Reflux. J Clin Med. 2022;11(21):6441. https://doi.org/10.3390/jcm11216441
36. Ospanov O, Nadirov K, Koikov V, Zharov N. One anastomosis gastric bypass with fundoplication of remnant stomach for weight regain prevention: Case report. Int J Surg Case Rep. 2022;97:107431. https://doi.org/10.1016/j.ijscr.2022.107431
##submission.downloads##
Жарыяланганы
Як цитувати
Номер
Розділ
